High Stakes, High Concentrations: Inside Biologics Innovation (Part 1)
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In today’s pharma landscape, patient convenience and drug delivery innovation go hand in hand. But how do you deliver life-saving biologics at higher concentrations without sacrificing safety, stability, or patient comfort?
In this live-recorded episode of Life Science Solutions, host Chris Adkins sits down with Ryan Doxey, Vice President of Technical Services at Kymanox, for part one of their conversation together. Ryan unpacks the opportunities and challenges of hyper-concentrated formulations, from why patients stand to benefit to how technical hurdles like viscosity, stability, and scale-up shape the path forward.
Chris and Ryan dig into what makes high-concentration biologics both technically challenging and clinically promising.
Topics Include:
- Why high-concentration biologics matter for patient convenience and compliance
- The science of formulation: balancing potency, viscosity, and stability
- Scale-up and manufacturing barriers innovators must solve
- Lifecycle management and the competitive edge of delivery innovation
This is part one of a two-part conversation with Ryan Doxey, offering an inside look at how advanced biologics are being reimagined for the patients who need them most.
📍 Recorded live during the Podcast Marathon at Walk West studio in Raleigh North Carolina.
#Biologics #DrugDelivery #PharmaInnovation #CMC #LifeSciences